Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: Does it signify a different nosologic entity from its systemic counterpart?

Background and Aim: Inflammatory myofibroblastic tumors (IMFTs) are uncommon neoplasms of the central nervous system (CNS) of intermediate grade biologic potential. Anaplastic lymphoma kinase (ALK-1), a diagnostic marker of anaplastic large cell lymphoma, is also expressed in a subset of IMFTs and a...

Full description

Bibliographic Details
Main Authors: Aparna Govindan, Anita Mahadevan, Shrijeet Chakraborti, Sunil Furtado, Susarla Krishna
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=2;spage=178;epage=182;aulast=Govindan
id doaj-6dc5e9e61063437baaac97c15a36bb36
record_format Article
spelling doaj-6dc5e9e61063437baaac97c15a36bb362020-11-25T00:56:34ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292014-01-0157217818210.4103/0377-4929.134658Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: Does it signify a different nosologic entity from its systemic counterpart?Aparna GovindanAnita MahadevanShrijeet ChakrabortiSunil FurtadoSusarla KrishnaBackground and Aim: Inflammatory myofibroblastic tumors (IMFTs) are uncommon neoplasms of the central nervous system (CNS) of intermediate grade biologic potential. Anaplastic lymphoma kinase (ALK-1), a diagnostic marker of anaplastic large cell lymphoma, is also expressed in a subset of IMFTs and appears to have prognostic significance. Though, few studies have evaluated expression of ALK-1 in IMFTs of the CNS. This retrospective study was undertaken to evaluate the expression of ALK-1 expression in IMFT of CNS by immunohistochemistry and correlate with the clinical, radiological and pathologic features. Materials and Methods: Five cases diagnosed as IMFT/inflammatory pseudotumour/plasma cell granuloma, diagnosed in CNS over 10 year period (1998-2007) were retrieved from the archives of Department of Neuropathology of a tertiary referralcenter. The clinical profile and imaging features were collected from the case records. Hematoxylin and eosin stained sections were reviewed with immunohistochemistry for smooth muscle actin (SMA), vimentin, desmin, ALK-1, p53, MIB-1, CD68, leukocyte common antigen, CD3, and CD20. Results: All five cases of IMFTs presented as dural-based space occupying or en-plaque lesions. Histologically, four cases had combined plasma cell granuloma-fibrous histiocytoma morphology, and one had fibrous histiocytoma-like morphology. Immunohistochemically, SMA was strongly positive in spindle cell component of the tumors confirming diagnosis. ALK-1 expression could not be detected by immunohistochemistry in any of the cases. Conclusion: Further studies analyzing ALK-1 gene mutation and rearrangements are required to determine pathogenetic role, if any, in CNS IMFTs.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=2;spage=178;epage=182;aulast=GovindanAnaplastic lymphoma kinasecentral nervous systeminflammatory myofibroblastic tumorcentral nervous systeminflammatory myofibroblastic tumor
collection DOAJ
language English
format Article
sources DOAJ
author Aparna Govindan
Anita Mahadevan
Shrijeet Chakraborti
Sunil Furtado
Susarla Krishna
spellingShingle Aparna Govindan
Anita Mahadevan
Shrijeet Chakraborti
Sunil Furtado
Susarla Krishna
Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: Does it signify a different nosologic entity from its systemic counterpart?
Indian Journal of Pathology and Microbiology
Anaplastic lymphoma kinase
central nervous system
inflammatory myofibroblastic tumor
central nervous system
inflammatory myofibroblastic tumor
author_facet Aparna Govindan
Anita Mahadevan
Shrijeet Chakraborti
Sunil Furtado
Susarla Krishna
author_sort Aparna Govindan
title Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: Does it signify a different nosologic entity from its systemic counterpart?
title_short Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: Does it signify a different nosologic entity from its systemic counterpart?
title_full Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: Does it signify a different nosologic entity from its systemic counterpart?
title_fullStr Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: Does it signify a different nosologic entity from its systemic counterpart?
title_full_unstemmed Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: Does it signify a different nosologic entity from its systemic counterpart?
title_sort absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: does it signify a different nosologic entity from its systemic counterpart?
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Pathology and Microbiology
issn 0377-4929
publishDate 2014-01-01
description Background and Aim: Inflammatory myofibroblastic tumors (IMFTs) are uncommon neoplasms of the central nervous system (CNS) of intermediate grade biologic potential. Anaplastic lymphoma kinase (ALK-1), a diagnostic marker of anaplastic large cell lymphoma, is also expressed in a subset of IMFTs and appears to have prognostic significance. Though, few studies have evaluated expression of ALK-1 in IMFTs of the CNS. This retrospective study was undertaken to evaluate the expression of ALK-1 expression in IMFT of CNS by immunohistochemistry and correlate with the clinical, radiological and pathologic features. Materials and Methods: Five cases diagnosed as IMFT/inflammatory pseudotumour/plasma cell granuloma, diagnosed in CNS over 10 year period (1998-2007) were retrieved from the archives of Department of Neuropathology of a tertiary referralcenter. The clinical profile and imaging features were collected from the case records. Hematoxylin and eosin stained sections were reviewed with immunohistochemistry for smooth muscle actin (SMA), vimentin, desmin, ALK-1, p53, MIB-1, CD68, leukocyte common antigen, CD3, and CD20. Results: All five cases of IMFTs presented as dural-based space occupying or en-plaque lesions. Histologically, four cases had combined plasma cell granuloma-fibrous histiocytoma morphology, and one had fibrous histiocytoma-like morphology. Immunohistochemically, SMA was strongly positive in spindle cell component of the tumors confirming diagnosis. ALK-1 expression could not be detected by immunohistochemistry in any of the cases. Conclusion: Further studies analyzing ALK-1 gene mutation and rearrangements are required to determine pathogenetic role, if any, in CNS IMFTs.
topic Anaplastic lymphoma kinase
central nervous system
inflammatory myofibroblastic tumor
central nervous system
inflammatory myofibroblastic tumor
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=2;spage=178;epage=182;aulast=Govindan
work_keys_str_mv AT aparnagovindan absenceofanaplasticlymphomakinase1expressionininflammatorymyofibroblastictumorsofthecentralnervoussystemdoesitsignifyadifferentnosologicentityfromitssystemiccounterpart
AT anitamahadevan absenceofanaplasticlymphomakinase1expressionininflammatorymyofibroblastictumorsofthecentralnervoussystemdoesitsignifyadifferentnosologicentityfromitssystemiccounterpart
AT shrijeetchakraborti absenceofanaplasticlymphomakinase1expressionininflammatorymyofibroblastictumorsofthecentralnervoussystemdoesitsignifyadifferentnosologicentityfromitssystemiccounterpart
AT sunilfurtado absenceofanaplasticlymphomakinase1expressionininflammatorymyofibroblastictumorsofthecentralnervoussystemdoesitsignifyadifferentnosologicentityfromitssystemiccounterpart
AT susarlakrishna absenceofanaplasticlymphomakinase1expressionininflammatorymyofibroblastictumorsofthecentralnervoussystemdoesitsignifyadifferentnosologicentityfromitssystemiccounterpart
_version_ 1725226477431029760